efanesoctocog alfa shows promise as treatment for previously treated severe hemophilia a
Published 1 year ago • 408 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
3:38
mechanism of action of efanesoctocog alfa to treat hemophilia a
-
54:36
efanesoctocog: a truly long-acting fviii replacement product
-
5:01
hemophilia: updated positive interim data from phase 2/3 study of marzeptacog alfa
-
9:36
hemophilia (year of the zebra)
-
3:34
hemophilia overview
-
59:03
new hemophilia treatments: implications for the coagulation laboratory
-
2:03
what is hemophilia?
-
1:34
understanding hemophilia
-
7:13
hemophilia a vs hemophilia b | genetics, symptoms and treatment
-
45:34
stop the bleeding - an update on hemophilia treatment
-
18:51
isth academy presentation: half-life extended factor viii for the treatment of hemophilia a
-
4:06
what are clotting factor replacement therapies and why are they needed?
-
31:07
hemophilia
-
2:12
improving outcomes in hemophilia a
-
3:22
clotting cascade, a national hemophilia foundation animation
-
7:41
haemophilia
-
57:07
11/16/18: the end of hemophilia?
-
2:06
emicizumab prophylaxis in hemophilia a
-
5:20
clot control: a story about hemophilia | cincinnati children's